|
|
|
|
||
Re: These big swings Positive p3 results for Elagolix in UF certainly enhances the chance for a buyout. We are now 90 days away from presumed approval for that drug for endometriosis, and application for approval for UF might not be far behind. With approval for Elagolix in endo, we might see a buyout offer/announcement in 100 days. I think coldpizza's $125 number is very reasonable and doable. I will sell mine for that number today to anyone who thinks it could be more. |
return to message board, top of board |